Sobi bets $250M cash, about $1B in milestones for rights to a C3 therapy
28 Oct 2020 //
ENDPTS
Novimmune unit nabs Takeda milestone payment for hemophilia work
14 Feb 2020 //
FIERCE BIOTECH
Sobi buys rare-disease drug emapalumab, zooms in on hematology and immunology
13 Jun 2019 //
REUTERS
Sobi Acquires Emapalumab and Related Assets
12 Jun 2019 //
PR NEWSWIRE
Sobi to buy Novimmune R&D assets, lay off 90 staff
12 Jun 2019 //
FIERCE BIOTECH